Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Year-over-year net income growth rate
Percentile
P3
Near historical low
vs 2Y Ago
-3755.5x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -2846.72% |
| Q3 2025 | -234.31% |
| Q2 2025 | 102.09% |
| Q1 2025 | 39.87% |
| Q4 2024 | 29.13% |
| Q3 2024 | -33.02% |
| Q2 2024 | 15.47% |
| Q1 2024 | 17.40% |
| Q4 2023 | 0.76% |
| Q3 2023 | -125.68% |
| Q2 2023 | -66.79% |
| Q1 2023 | -11.08% |
| Q4 2022 | -7246.99% |
| Q3 2022 | 100.82% |
| Q2 2022 | -20.05% |
| Q1 2022 | 11.22% |
| Q4 2021 | 25.64% |
| Q3 2021 | -8.95% |
| Q2 2021 | -1158.01% |
| Q1 2021 | 92.79% |
| Q4 2020 | -23.76% |
| Q3 2020 | -11.45% |
| Q2 2020 | 4.20% |
| Q1 2020 | -28.61% |
| Q4 2019 | -25.40% |
| Q3 2019 | 13.01% |
| Q2 2019 | 6.39% |
| Q1 2019 | 1.31% |
| Q4 2018 | -12.45% |
| Q3 2018 | -13.09% |
| Q2 2018 | -217.98% |
| Q1 2018 | -30.59% |
| Q4 2017 | -5.59% |
| Q3 2017 | -24.11% |
| Q2 2017 | -92.11% |
| Q1 2017 | 0.00% |